Health care stocks were flat to higher premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) inactive.
Soleno Therapeutics (SLNO) shares were up 35% after the company said overnight that the US Food and Drug Administration has approved its treatment for hyperphagia in adults and children with Prader-Willi Syndrome, a rare genetic disorder.
Bausch + Lomb (BLCO) stock was more than 4% lower after the company said it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.
Ascentage Pharma Group (AAPG) shares were up over 10% after the company reported a narrower 2024 loss as revenue rose during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.